Indicated for: hypertension
Route of administration: oral
Substance: nebivolol + hydrochlorothiazide (beta blocker + diuretic)
ATC: C07BB12 (Cardiovascular system | Beta blocking agents and thiazides | Beta blocking agents, selective, and thiazides)
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
Avoid excessive exposure to sunlight or UV radiation.
May lower blood pressure and increase the risk of falls.
Periodic laboratory tests may be required during treatment.
Older people may have an increased risk of side effects.
This medicine may change blood electrolyte levels.
Nebivolol and hydrochlorothiazide are used together to treat high blood pressure (hypertension). Nebivolol is a beta-blocker that helps relax blood vessels and reduce heart rate, thereby lowering blood pressure. Hydrochlorothiazide is a diuretic that helps remove excess water and salt from the body, reducing blood volume and blood pressure.
This combination is effective in reducing the risk of cardiovascular complications, such as heart attacks and strokes, in patients with hypertension. It is important to take the medication as prescribed by your doctor to achieve the best results.
Nebivolol is well-tolerated by most patients but may cause side effects such as fatigue, dizziness, or headaches. Hydrochlorothiazide may lead to potassium loss, requiring regular monitoring of electrolyte levels.
Patients should inform their doctor about any other medications they are taking, as this combination may interact with other treatments. Additionally, maintaining a healthy lifestyle, including a balanced diet and regular exercise, is essential to support the treatment of high blood pressure.